Trial Profile
A study to evaluate the risk of metabolic syndrome, cardiovascular risk, and renal impairment in HIV-infected patients initiating antiretroviral therapy (ART) in the GUESS cohort.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 01 Mar 2016
Price :
$35
*
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Adverse reactions
- Acronyms GUESS
- 01 Mar 2016 New trial record